PERSONALIS INC

Personalis Inc. (PSNL) shares fell 0.25% to $15.85, amid a 2.81% monthly dip, while its $1.7 B market cap, 200‑day MA, and 52‑week range are highlighted in the latest market snapshot.

Personalis Inc. (PSNL) trades near its 200‑day average amid a market‑wide pause, but its precision‑medicine pipeline and oncology focus signal potential upside. Click to learn why investors eye this genomic leader.

Personalis shares rise 0.38% to $15.90 as the genomics firm’s $1.7B market cap edges upward, reflecting steady growth amid broader positive market sentiment.